More about

Endometrial Cancer

News
May 03, 2021
2 min read
Save

Adavosertib monotherapy active in recurrent uterine serous carcinoma

Adavosertib monotherapy active in recurrent uterine serous carcinoma

Adavosertib demonstrated clinical activity among women with recurrent uterine serous carcinoma, according to results of a phase 2 study published in Journal of Clinical Oncology.

News
April 29, 2021
1 min read
Save

Top in hem/onc: CAR-T for diffuse midline gliomas, new endometrial cancer therapy

Top in hem/onc: CAR-T for diffuse midline gliomas, new endometrial cancer therapy

Researchers recently presented early data on the efficacy of chimeric antigen receptor T-cell therapy for diffuse midline gliomas during the virtual American Association for Cancer Research Annual Meeting.

News
April 22, 2021
1 min read
Save

FDA approves Jemperli for endometrial cancer subset

FDA approves Jemperli for endometrial cancer subset

The FDA granted accelerated approval to dostarlimab-gxly for treatment of certain women with endometrial cancer.

News
March 30, 2021
2 min read
Save

Adjuvant therapy does not extend survival in high-risk endometrial cancer

Adjuvant therapy does not extend survival in high-risk endometrial cancer

Postoperative systemic or radiation therapy did not extend survival for women with high-risk stage I endometrial cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 29, 2021
3 min read
Save

Interventions overcome endometrial cancer clinical trial inequity in Deep South

Interventions overcome endometrial cancer clinical trial inequity in Deep South

Interventions designed to improve care for Black women with endometrial cancer can help overcome clinical trial inequities, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 26, 2021
3 min read
Save

Levonorgestrel intrauterine device induces response in early endometrial cancer, precancer

Levonorgestrel intrauterine device induces response in early endometrial cancer, precancer

Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.

News
March 24, 2021
2 min read
Save

Time to surgery linked to survival among women with high-grade endometrial cancer

Time to surgery linked to survival among women with high-grade endometrial cancer

Regionalization of care for high-grade endometrial cancer in Ontario had no negative effect on surgical wait times, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 22, 2021
3 min read
Save

Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer

Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer

Lenvatinib plus pembrolizumab improved outcomes vs. chemotherapy for women with advanced endometrial cancer, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 09, 2021
3 min read
Save

High cadmium intake linked to shorter OS among women with endometrial cancer

High cadmium intake linked to shorter OS among women with endometrial cancer

High daily dietary cadmium intake appeared associated with shorter OS among women with endometrial cancer, according to study results published in Nutrition and Cancer.

News
February 19, 2021
1 min read
Save

Rutgers Cancer Institute of New Jersey names gynecologic oncology chief

Rutgers Cancer Institute of New Jersey names gynecologic oncology chief

James K. Aikins Jr., MD, FACOG, FACS, has been appointed chief of gynecologic oncology at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital.

View more